SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Section 1: Identification
Product identifier:

Estradiol Gel Formulation

Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable
Manufacturer or supplier's details
Company: Organon & Co.
Address:

30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302

Telephone:+1-551-430-6000

Emergency telephone number :+1-215-631-6999

E-mail address

EHSSTEWARD@organon.com:

Section 2: Hazard identification
Classification of the substance or mixture
Flammable liquids: Category 2
Serious eye damage/eye irritation:

Category 2

Carcinogenicity:

Category 1A

Reproductive toxicity:

Category 1ASpecific target organ toxicity repeated exposure:

Category 1 (Liver, Bone, Blood, Endocrine system)

Long-term (chronic) aquatic
hazard:Category 1

GHS Label elements, including precautionary statements
Hazard pictograms:

Signal word:

DangerHazard statements:

H225 Highly flammable liquid and vapour.
1 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

H319 Causes serious eye irritation.
H350 May cause cancer.
H360FD May damage fertility. May damage the unborn child.
H372 Causes damage to organs (Liver, Bone, Blood, Endocrine system) through prolonged or repeated exposure.
H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements:

Prevention:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been readand understood.
P210 Keep away from heat, hot surfaces, sparks, open flames
and other ignition sources. No smoking.
P233 Keep container tightly closed.
P241 Use explosion-proof electrical/ ventilating/ lighting equipment.
P242 Use non-sparking tools.
P243 Take action to prevent static discharges.
P260 Do not breathe vapours.
P264 Wash skin thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P273 Avoid release to the environment.
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Response:
P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water
for several minutes. Remove contact lenses, if present andeasy to do. Continue rinsing.
P308 + P313 IF exposed or concerned: Get medical advice/attention.
P337 + P313 If eye irritation persists: Get medical advice/ attention.
P391 Collect spillage.
Storage:
P403 + P235 Store in a well-ventilated place. Keep cool.
P405 Store locked up.
Disposal:
P501 Dispose of contents/ container to an approved waste
disposal plant.

Other hazards which do not result in classification
Vapours may form explosive mixture with air.
Section 3: Composition/information on ingredients
Substance / Mixture:

Mixture2 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Components
Chemical name
Ethanol#
Estradiol# Voluntarily-disclosed substance

CAS-No.
64-17-550-28-2

Concentration (% w/w)
58.5
0.1

Section 4: First-aid measures
Description of necessary first-aid measures
General advice: In the case of accident or if you feel unwell, seek medical advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.
If inhaled: If inhaled, remove to fresh air.
Get medical attention.
In case of skin contact: In case of contact, immediately flush skin with soap and plentyof water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
In case of eye contact: In case of contact, immediately flush eyes with plenty of water
for at least 15 minutes.
If easy to do, remove contact lens, if worn.
Get medical attention.
If swallowed: If swallowed, DO NOT induce vomiting.
Get medical attention.
Rinse mouth thoroughly with water.
Most important symptoms and effects, both acute and delayed
Risks: Causes serious eye irritation.
May cause cancer.
May damage fertility. May damage the unborn child.
Causes damage to organs through prolonged or repeatedexposure.
Protection of first-aiders: First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Indication of any immediate medical attention and special treatment needed
Treatment: Treat symptomatically and supportively.
Section 5: Fire-fighting measures
Extinguishing media
Suitable extinguishing media:

Unsuitable extinguishing:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemicalHigh volume water jet
3 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

media
Special hazards arising from the substance or mixture
Specific hazards during fire- : Do not use a solid water stream as it may scatter and spreadfighting
fire.
Flash back possible over considerable distance.
Vapours may form explosive mixtures with air.
Exposure to combustion products may be a hazard to health.
Hazardous combustion products:

Carbon oxides

Special protective actions for fire-fighters
Special protective equipment : In the event of fire, wear self-contained breathing apparatus.
for firefighters
Use personal protective equipment.
Specific extinguishing meth- : Use extinguishing measures that are appropriate to local cirods
cumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to doso.
Evacuate area.
Section 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Personal precautions: Remove all sources of ignition.
Ventilate the area.
Use personal protective equipment.
Follow safe handling advice (see section 7) and personal protective equipment recommendations (see section 8).
Environmental precautions
Environmental precautions:

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Prevent spreading over a wide area (e.g. by containment or oilbarriers).
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

Methods and materials for containment and cleaning up
Methods for cleaning up: Non-sparking tools should be used.
Soak up with inert absorbent material.
Suppress (knock down) gases/vapours/mists with a water
spray jet.
For large spills, provide dyking or other appropriate containment to keep material from spreading. If dyked material canbe pumped, store recovered material in appropriate container.
Clean up remaining materials from spill with suitable absorbent.
Local or national regulations may apply to releases and disposal of this material, as well as those materials and items
4 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

employed in the cleanup of releases. You will need to determine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.
Section 7: Handling and storage
Precautions for safe handlingTechnical measures:
Local/Total ventilation:

Advice on safe handling:

Hygiene measures:

See Engineering measures under EXPOSURE
CONTROLS/PERSONAL PROTECTION section.
If sufficient ventilation is unavailable, use with local exhaust
ventilation.
Use explosion-proof electrical, ventilating and lighting equipment.
Do not get on skin or clothing.
Do not breathe vapours.
Do not swallow.
Do not get in eyes.
Wash skin thoroughly after handling.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure assessment
Non-sparking tools should be used.
Keep container tightly closed.
Keep away from heat, hot surfaces, sparks, open flames andother ignition sources. No smoking.
Take precautionary measures against static discharges.
Do not eat, drink or smoke when using this product.
Take care to prevent spills, waste and minimize release to theenvironment.
If exposure to chemical is likely during typical use, provide eye
flushing systems and safety showers close to the working
place.
When using do not eat, drink or smoke.
Wash contaminated clothing before re-use.
The effective operation of a facility should include review ofengineering controls, proper personal protective equipment,
appropriate degowning and decontamination procedures,industrial hygiene monitoring, medical surveillance and theuse of administrative controls.

Conditions for safe storage, including any incompatibilities
Conditions for safe storage: Keep in properly labelled containers.
Store locked up.
Keep tightly closed.
Keep in a cool, well-ventilated place.
Store in accordance with the particular national regulations.
Keep away from heat and sources of ignition.
Materials to avoid: Do not store with the following product types:
Self-reactive substances and mixtures
Organic peroxides
5 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Oxidizing agents
Flammable gases
Pyrophoric liquids
Pyrophoric solids
Self-heating substances and mixtures
Poisonous gases
Explosives
Section 8: Exposure controls/personal protection
Control parameters
Occupational Exposure Limits
Components

CAS-No.

Ethanol

64-17-5

Estradiol50-28-2

Value type
(Form ofexposure)
PEL (long
term)
STEL
TWA

Further information: Skin
Wipe limit
Appropriate engineering
control measures:

Control parameters / Permissible
concentration
1,000 ppm
1,880 mg/m3
1,000 ppm
0.05 µg/m3 (OEB
5)

Basis

0.5 µg/100 cm²Internal

SG OELACGIHInternal

Use closed processing systems or containment technologies
to control at source (e.g., glove boxes/isolators) and to prevent leakage of compounds into the workplace.
All engineering controls should be implemented by facility
design and operated in accordance with GMP principles toprotect products, workers, and the environment.
No open handling permitted.
Totally enclosed processes and materials transport systems
are required.
Operations require the use of appropriate containment technology designed to prevent leakage of compounds into theworkplace.
Use explosion-proof electrical, ventilating and lighting equipment.

Individual protection measures, such as personal protective equipment (PPE)
Eye/face protection: Wear safety glasses with side shields or goggles.
If the work environment or activity involves dusty conditions,mists or aerosols, wear the appropriate goggles.
Wear a faceshield or other full face protection if there is apotential for direct contact to the face with dusts, mists, oraerosols.
Skin protection: Work uniform or laboratory coat.
Additional body garments should be used based upon thetask being performed (e.g., sleevelets, apron, gauntlets, dis6 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Respiratory protection:

Filter type
Hand protection:

posable suits) to avoid exposed skin surfaces.
Use appropriate degowning techniques to remove potentiallycontaminated clothing.
If adequate local exhaust ventilation is not available or exposure assessment demonstrates exposures outside the recommended guidelines, use respiratory protection.
Combined particulates and organic vapour type

Material:

Chemical-resistant gloves

Remarks:

Consider double gloving. Take note that the product is flammable, which may impact the selection of hand protection.

Section 9: Physical and chemical properties
Appearance:

gelColour:opalescent

Odour

:

aromatic

Odour Threshold:

No data available

pH:

No data available

Melting point/freezing point:

No data available

Initial boiling point and boiling
range

:

No data available

Flash point

:

22 °C
Method: closed cup

Evaporation rate:

No data available

Flammability (solid, gas):

Not applicable

Flammability (liquids):

Ignitable (see flash point)

Upper explosion limit / Upper
flammability limit:

No data available

Lower explosion limit / Lower
flammability limit:

No data available

Vapour pressure:

No data available

Relative vapour density:

No data available

Relative density:

No data available

7 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Density:

No data available

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water
Auto-ignition temperature:

Not applicable:

No data available

Decomposition temperature:

No data available

Viscosity
Viscosity, kinematic:

No data available

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.

Molecular weight:

No data available

Particle characteristics
Particle size:

Not applicable

Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
Highly flammable liquid and vapour.
Vapours may form explosive mixture with air.
Can react with strong oxidizing agents.

Conditions to avoid
Incompatible materials
Hazardous decomposition
products:::

Heat, flames and sparks.
Oxidizing agents
No hazardous decomposition products are known.

Section 10: Stability and reactivity

Section 11: Toxicological information
Information on likely routes of :exposure

Inhalation
Skin contact
Ingestion
Eye contact

Acute toxicity
Not classified based on available information.
Components:
Ethanol:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg
8 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Method: OECD Test Guideline 401
Acute inhalation toxicity:

LC50 (Rat): 124.7 mg/l
Exposure time: 4 h
Test atmosphere: vapour

Estradiol:
Acute oral toxicity:

LD50 (Rat): > 2,000 mg/kg

Acute toxicity (other routes of :administration)

LD50 (Rat): > 300 mg/kg
Application Route: Subcutaneous

Skin corrosion/irritation
Not classified based on available information.
Components:
Ethanol:
Species
MethodResult:::RabbitOECD Test Guideline 404
No skin irritation

Serious eye damage/eye irritation
Causes serious eye irritation.
Components:
Ethanol:
SpeciesResult
Method:::RabbitIrritation to eyes, reversing within 21 days
OECD Test Guideline 405

Estradiol:
Result:No eye irritation

Respiratory or skin sensitisation
Skin sensitisation
Not classified based on available information.
Respiratory sensitisation
Not classified based on available information.
Components:
Ethanol:
Test Type
Exposure routes
SpeciesResult::::Local lymph node assay (LLNA)
Skin contact
Mouse
negative
9 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

Estradiol:
Exposure routes
Species
Assessment
ResultSDS Number:
10608789-00007

:
:
:
:

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Skin contact
Guinea pig
Does not cause skin sensitisation.
negative

Germ cell mutagenicity
Not classified based on available information.
Components:
Ethanol:
Genotoxicity in vitro:

Test Type: In vitro mammalian cell gene mutation test
Result: negative
Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Genotoxicity in vivo:

Test Type: Rodent dominant lethal test (germ cell) (in vivo)
Species: Mouse
Application Route: Ingestion
Result: equivocal

Estradiol:
Genotoxicity in vitro:

Test Type: DNA damage and repair, unscheduled DNA synthesis in mammalian cells (in vitro)
Test system: mammalian cells
Result: positive
Test Type: Chromosome aberration test in vitro
Test system: mammalian cells
Result: positive
Test Type: Chromosomal aberration
Test system: mammalian cells
Result: positive

Genotoxicity in vivo:

Test Type: Chromosomal aberration
Species: Rat
Cell type: Bone marrow
Result: negative
Test Type: Chromosomal aberration
Species: Mouse
Cell type: Bone marrow
Result: negative

Carcinogenicity
May cause cancer.
10 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Components:
Estradiol:
Species
Application RouteExposure time
LOAEL
ResultTarget Organs

:
:
:
:
:
:

Mouse
Ingestion
24 Months
100 µg/kg
positive
female reproductive organs

Species
Application RouteExposure time
LOAEL
ResultTarget Organs

:
:
:
:
:
:

Rat
Subcutaneous
13 weeks
20 mg/kg body weight
positive
Endocrine system

Carcinogenicity - Assessment:

Positive evidence from human epidemiological studies

Reproductive toxicity
May damage fertility. May damage the unborn child.
Components:
Ethanol:
Effects on fertility:

Test Type: Two-generation reproduction toxicity study
Species: Mouse
Application Route: Ingestion
Result: negative

Estradiol:
Effects on fertility:

Test Type: One-generation reproduction toxicity study
Species: Rat
Application Route: Ingestion
Fertility: LOAEL: 0.5 mg/kg body weight
Result: Effects on fertility
Test Type: One-generation reproduction toxicity study
Species: Rat
Duration of Single Treatment: 90 d
Fertility: LOAEL: 0.69 mg/kg body weight
Result: Effects on fertility
Test Type: Two-generation study
Species: Mouse
Application Route: Oral
Fertility: LOAEL: 0.1 mg/kg body weight
Result: Effects on fertility

Effects on foetal development:

Test Type: Embryo-foetal development
Species: Mouse, female
11 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

Application Route: Subcutaneous
Teratogenicity: LOAEL: 4 mg/kg body weight
Symptoms: Malformations were observed.
Result: positive, Teratogenic effects
Test Type: One-generation reproduction toxicity study
Species: Rat
Application Route: Subcutaneous
Teratogenicity: LOAEL: 2.5 µg/kg body weight
Symptoms: Reduced body weight
Result: positive, Embryotoxic effects and adverse effects on
the offspring were detected.
Test Type: Embryo-foetal development
Species: Rat
Application Route: Subcutaneous
Developmental Toxicity: LOAEL: 0.2 mg/kg body weight
Symptoms: Early Resorptions / resorption rate, Reduced
number of viable fetuses, Reduced body weight
Result: Embryotoxic effects and adverse effects on the offspring were detected only at high maternally toxic doses
Reproductive toxicity - Assessment:

May damage fertility. May damage the unborn child.

STOT - single exposure
Not classified based on available information.
STOT - repeated exposure
Causes damage to organs (Liver, Bone, Blood, Endocrine system) through prolonged or repeatedexposure.
Components:
Estradiol:
Target Organs
Assessment::

Liver, Bone, Blood, Endocrine system
Causes damage to organs through prolonged or repeatedexposure.

Ethanol:
Species
NOAEL
LOAEL
Application RouteExposure time

:
:
:
:
:

Rat
1,280 mg/kg
3,156 mg/kg
Ingestion
90 Days

Estradiol:
Species:Rat

Repeated dose toxicity
Components:

12 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

LOAEL
Application RouteExposure timeTarget Organs

SDS Number:
10608789-00007

:
:
:
:

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022>= 0.17 mg/kg
Ingestion
90 d
Mammary gland, Ovary, Uterus (including cervix), Liver, Bone,
Endocrine system, Blood, Testis

Aspiration toxicity
Not classified based on available information.
Experience with human exposure
Components:
Estradiol:
Inhalation
Skin contact
Ingestion:::

Symptoms: tingling, Nose bleeding
Symptoms: Skin irritation, Redness, pruritis
Symptoms: Headache, Gastrointestinal disturbance, Dizziness, Vomiting, Diarrhoea, water retention, liver functionchange, changes in libido, breast tenderness, menstrual irregularities

Section 12: Ecological information
Toxicity
Components:
Ethanol:
Toxicity to fish:

LC50 (Pimephales promelas (fathead minnow)): > 1,000 mg/l
Exposure time: 96 h

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Ceriodaphnia (water flea)): > 1,000 mg/l
Exposure time: 48 h

Toxicity to algae/aquaticplants:

ErC50 (Chlorella vulgaris (Fresh water algae)): 275 mg/l
Exposure time: 72 h
EC10 (Chlorella vulgaris (Fresh water algae)): 11.5 mg/l
Exposure time: 72 h

Toxicity to daphnia and other :aquatic invertebrates (Chronic toxicity)
Toxicity to microorganisms:

NOEC (Daphnia magna (Water flea)): 9.6 mg/l
Exposure time: 9 d
EC50 (Pseudomonas putida): 6,500 mg/l
Exposure time: 16 h

Estradiol:
Toxicity to fish:

LC50 (Oryzias latipes (Japanese medaka)): 3.9 mg/l
Exposure time: 96 h

Toxicity to daphnia and other:

EC50 (Daphnia magna (Water flea)): 2.7 mg/l
13 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

aquatic invertebrates
Toxicity to algae/aquaticplantsDate of last issue: 30.09.2023
Date of first issue: 08.02.2022

Exposure time: 48 h:

NOEC (Pseudokirchneriella subcapitata (green algae)): 1.7
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
EC50 (Pseudokirchneriella subcapitata (green algae)): > 1.7
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201

Toxicity to fish (Chronic toxicity):

Toxicity to daphnia and other :aquatic invertebrates (Chronic toxicity)
M-Factor (Chronic aquatic:
toxicity)
Toxicity to microorganisms:

NOEC (Oryzias latipes (Japanese medaka)): 0.000003 mg/l
Exposure time: 160 d
Method: OECD Test Guideline 210
NOEC (Daphnia magna (Water flea)): 0.2 mg/l
Exposure time: 21 d
1,000
EC50: > 100 mg/l
Exposure time: 3 hTest Type: Respiration inhibition
Method: OECD Test Guideline 209
NOEC: 100 mg/l
Exposure time: 3 hTest Type: Respiration inhibition
Method: OECD Test Guideline 209

Persistence and degradability
Components:
Ethanol:
Biodegradability:

Result: Readily biodegradable.
Biodegradation: 84 %Exposure time: 20 d

Estradiol:
Biodegradability:

Result: rapidly degradable
Biodegradation: 84 %Exposure time: 24 hrs:

log Pow: -0.35

Bioaccumulative potential
Components:
Ethanol:
Partition coefficient: n-

14 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

octanol/water
Estradiol:
Partition coefficient: noctanol/water:log Pow: 4.01:

log Koc: 3.81

Mobility in soil
Components:
Estradiol:
Distribution among environmental compartments
Other adverse effects
No data available
Section 13: Disposal considerations
Disposal methods
Waste from residues:

Contaminated packaging:

Do not dispose of waste into sewer.
Dispose of in accordance with local regulations.
Empty containers should be taken to an approved waste handling site for recycling or disposal.
Empty containers retain residue and can be dangerous.
Do not pressurize, cut, weld, braze, solder, drill, grind, or expose such containers to heat, flame, sparks, or other sourcesof ignition. They may explode and cause injury and/or death.
If not otherwise specified: Dispose of as unused product.

Section 14: Transport information
International Regulations
UNRTDGUN numberUN proper shipping name
Transport hazard class(es)Packing group
LabelsEnvironmental hazards
IATA-DGR
UN/ID No.
UN proper shipping name
Transport hazard class(es)Packing group
LabelsPacking instruction (cargo
aircraft)Packing instruction (passenger aircraft)

:
:
:
:
:
:

UN 1170
ETHANOL SOLUTION
3
II
3
yes

:
:
:
:
:
:

UN 1170
Ethanol solution
3IIFlammable Liquids
364

:

353

IMDG-Code
15 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

SDS Number:
10608789-00007

UN number
Proper shipping name::

Transport hazard class(es)Packing group
LabelsEmS Code
Marine pollutant

:
:
:
:
:

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

UN 1170
ETHANOL SOLUTION(Estradiol)
3II
3F-E, S-D
yes

Transport in bulk according to IMO instruments
Not applicable for product as supplied.
Special precautions for user
The transport classification(s) provided herein are for informational purposes only, and solely
based upon the properties of the unpackaged material as it is described within this Safety Data
Sheet. Transportation classifications may vary by mode of transportation, package sizes, and variations in regional or country regulations.
Section 15: Regulatory information
Safety, health and environmental regulations specific for the product in question
Workplace Safety and Health Act and Workplace Safety and Health (General Provisions) Regulations: This product is subjected to the SDS, labelling, PEL and other requirements in the
Act/Regulations.
Environmental Protection and Management Act and: Not applicable
Environmental Protection and Management (Hazardous Substances) Regulations
Fire Safety (Petroleum and Flammable Materials)
Regulations:

Ethanol

The components of this product are reported in the following inventories:
AICS: not determinedDSL:

not determined

IECSC

:

not determined

Revision Date:

06.04.2024

Further information
Sources of key data used tocompile the Safety Data
Sheet

:

Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Section 16: Other information

Items where changes have been made to the previous version are highlighted in the body of thisdocument by two vertical lines.

16 / 17

SAFETY DATA SHEET

Estradiol Gel Formulation
Version
3.0

Revision Date:
06.04.2024

Date format

SDS Number:
10608789-00007:

Date of last issue: 30.09.2023
Date of first issue: 08.02.2022

dd.mm.yyyy

Full text of other abbreviations
ACGIH: USA. ACGIH Threshold Limit Values (TLV)
SG OEL: Singapore. Workplace Safety and Health (General Provisions)
Regulations - First Schedule Permissible Exposure Limits of
Toxic Substances.
ACGIH / STEL
SG OEL / PEL (long term)::

Short-term exposure limit
Permissible Exposure Level (PEL) Long Term

AIIC - Australian Inventory of Industrial Chemicals; ANTT - National Agency for Transport byLand of Brazil; ASTM - American Society for the Testing of Materials; bw - Body weight; CMR Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of the German Institute forStandardisation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with
x% response; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; IARC - International Agency for Research on Cancer; IATA
- International Air Transport Association; IBC - International Code for the Construction andEquipment of Ships carrying Dangerous Chemicals in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime Dangerous Goods; IMO - International
Maritime Organization; ISHL - Industrial Safety and Health Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to 50% of a test population (Median
Lethal Dose); MARPOL - International Convention for the Prevention of Pollution from Ships;
n.o.s. - Not Otherwise Specified; Nch - Chilean Norm; NO(A)EC - No Observed (Adverse) EffectConcentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable EffectLoading Rate; NOM - Official Mexican Norm; NTP - National Toxicology Program; NZIoC - New
Zealand Inventory of Chemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Office of Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; REACH - Regulation (EC) No
1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; SADT - Self-Accelerating Decomposition Temperature; SDS - Safety Data Sheet; TCSI - Taiwan Chemical Substance Inventory; TDG - Transportation of Dangerous Goods; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act (United States); UN - United Nations; UNRTDG - United Nations Recommendations on the Transport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative; WHMIS - Workplace Hazardous Materials Information System
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information is designed only as a guidance forsafe handling, use, processing, storage, transportation, disposal and release and shall not be
considered a warranty or quality specification of any type. The information provided relates only
to the specific material identified at the top of this SDS and may not be valid when the SDS material is used in combination with any other materials or in any process, unless specified in the text.
Material users should review the information and recommendations in the specific context of theirintended manner of handling, use, processing and storage, including an assessment of the appropriateness of the SDS material in the user’s end product, if applicable.
SG / EN
17 / 17